Business Context and Reporting Period
Company: Innovative Eyewear, Inc. (Ticker: LUCY)
Filing Type: Form 8-K (Current Report)
Date of Report: April 28, 2024
Event: Entry into a Material Definitive Agreement for a registered direct offering and concurrent private placement.
Key Financial Metrics and Transaction Details
| Metric | Value |
|---|---|
| Gross Proceeds Target | Approximately $1,000,000 |
| Common Shares Issued | 4,200,822 |
| Purchase Warrants Issued | 4,200,822 (1:1 ratio) |
| Combined Purchase Price | $0.244 per Share and Warrant |
| Warrant Exercise Price | $0.244 per share |
| Warrant Expiration | 5 years from initial exercise date |
| Placement Agent Fees | 6.0% cash fee + 1.0% management fee + $25,000 expenses + $15,950 clearing |
| Placement Agent Warrants | 315,062 shares at $0.305 exercise price |
| Estimated Net Proceeds | Approximately $832,300 |
Material Changes and Transaction Structure
- Capital Raise: The Company entered into a Securities Purchase Agreement to raise capital through a registered direct offering of common stock and a concurrent private placement of warrants.
- Dilution: The transaction involves the issuance of 4,200,822 shares of common stock immediately, with an additional 4,200,822 shares issuable upon exercise of Purchase Warrants, plus 315,062 shares issuable via Placement Agent Warrants.
- Regulatory Status: The common shares were sold pursuant to a prospectus supplement under an effective shelf registration (Form S-3). The warrants are being sold unregistered under Section 4(a)(2) and Rule 506 exemptions.
- Stockholder Approval: The Company must hold a shareholder meeting within 90 days of the Closing Date to approve the issuance of shares underlying the Purchase Warrants.
Guidance, Outlook, and Use of Proceeds
Use of Proceeds: The Company intends to use the net proceeds for general corporate purposes and working capital.
Closing Date: Expected on or about May 1, 2024, subject to customary closing conditions.
Registration Timeline: The Company agreed to file a registration statement for the resale of Warrant Shares within 30 days of the agreement and use commercially reasonable efforts to have it declared effective within 60 days (or 90 days in the event of a full review).
Investor Verification Checklist
- Verify the final closing date and actual gross proceeds received versus the $1 million target.
- Confirm the date of the shareholder meeting required to approve the warrant shares (must be within 90 days of closing).
- Review the effective date of the registration statement covering the resale of Warrant Shares.
- Monitor the Company's cash position post-closing to assess the impact of the $832,300 net proceeds on working capital.
- Check for any subsequent filings regarding the exercise of warrants or changes in the offering terms.